Genzyme Ireland Limited (secondary packaging, labeling, storage of medicinal products and batch release)

The drug is intended for monotherapy in adults with highly active relapsing-remitting multiple sclerosis (RRMS). It is used if the disease remains active despite previous treatment, or in cases of rapidly progressing severe disease.

Dosage form: concentrate for infusion solution

ATC: L04AA34